Ono Pharmaceutical (OTCMKTS:OPHLF) Share Price Passes Above 50 Day Moving Average – Here’s What Happened

Ono Pharmaceutical Co., Ltd. (OTCMKTS:OPHLF) passed above its 50 day moving average during trading on Monday . The stock has a 50 day moving average of $10.36 and traded as high as $11.19. Ono Pharmaceutical shares last traded at $11.19, with a volume of 13,701 shares trading hands.

Ono Pharmaceutical Stock Up 2.4 %

The stock has a 50-day moving average price of $10.36 and a 200-day moving average price of $11.43. The company has a debt-to-equity ratio of 0.14, a current ratio of 3.55 and a quick ratio of 2.80. The company has a market capitalization of $5.25 billion, a P/E ratio of 10.75 and a beta of 0.73.

Ono Pharmaceutical (OTCMKTS:OPHLF) last issued its quarterly earnings results on Monday, February 3rd. The company reported $0.21 earnings per share (EPS) for the quarter. Ono Pharmaceutical had a net margin of 15.15% and a return on equity of 9.10%.

Ono Pharmaceutical Company Profile

Ono Pharmaceutical Co, Ltd., together with its subsidiaries, produces, purchases, and sells pharmaceuticals and diagnostic reagents worldwide. It offers Opdivo Intravenous Infusion and Kyprolis Intravenous Injection for malignant tumors; Emend capsules/Proemend intravenous injections for chemotherapy-induced nausea and vomiting; Demser capsules for the symptoms in patients with pheochromocytoma; and Mektovi, Velexbru, and Braftovi capsules for malignant tumors, as well as ADLUMIZ tablets for cancer cachexia.